<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002020'>Gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) is the most common gastrointestinal diagnosis recorded during visits to outpatient clinics in west countries </plain></SENT>
<SENT sid="1" pm="."><plain>The prevalence of symptom-defined <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> in China is as high as 3% to 5% </plain></SENT>
<SENT sid="2" pm="."><plain>Asa dysfunction, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> is characterized by reflux and heartburns </plain></SENT>
<SENT sid="3" pm="."><plain>The pathophysiologic process of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> is very complicated and subtle </plain></SENT>
<SENT sid="4" pm="."><plain>The spectrum of injury from long-term reflux of acid or bile includes damage mucosa, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, the therapies of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> should focus on controlling symptom,treating complications, and surveillance the possibility of oncologic transform </plain></SENT>
<SENT sid="6" pm="."><plain>As with therapy with <z:chebi fb="0" ids="49200">proton-pump inhibitors</z:chebi> (<z:chebi fb="4" ids="53266">PPI</z:chebi>), modifying lifestyle is another most important modality for most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The window of surgical treatment for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> is narrow </plain></SENT>
<SENT sid="8" pm="."><plain>Surgical therapy is alternative management approach to the patients with <z:chebi fb="4" ids="53266">PPI</z:chebi> failure, complications, or huge <z:hpo ids='HP_0100790'>hernia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The laparoscopic minimally invasive procedure improves the acceptance of patients to surgical therapy, but the long-term complication and drawbacks of anti-reflux surgery cannot be ignored, and which is even more common than open procedures </plain></SENT>
<SENT sid="10" pm="."><plain>The limitations of current therapy for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> have encouraged a search for more effective treatment.The Linx sphincter augmentation device has been developed to address this gap with improvement of the barrier function of LES and reversible design if necessary </plain></SENT>
</text></document>